Gene targeting in vivo by adeno-associated virus vectors

Nature Biotechnology

Volumn 24, Issue 8, 2006, Pages 1022-1026

  Miller, Daniel G ^a   Wang, Pei Rong ^b   Petek, Lisa M ^a   Hirata, Roli K ^b   Sands, Mark S ^c   Russell, David W ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL CULTURE; CHROMOSOMES; DNA; ENZYMES; MUTAGENESIS; ONCOGENIC VIRUSES;

ADENO-ASSOCIATED VIRUS (AAV); CHROMOSOMAL SEQUENCES; GENE EXPRESSION; ROSA26 LOCUS;

GENETIC ENGINEERING;

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; SINGLE STRANDED DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; FEMALE; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENE TARGETING; GENETIC TRANSDUCTION; IN VIVO STUDY; LIVER CELL; MOUSE; MUCOPOLYSACCHARIDOSIS TYPE 7; MUTAGENESIS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ADENOVIRIDAE; ANIMALS; GENE TARGETING; GENETIC ENGINEERING; GENETIC VECTORS; MICE; MICE, INBRED C57BL; TRANSFECTION;

ADENO-ASSOCIATED VIRUS; MURINAE;

EID: 33747046320     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt1231     Document Type: Article

References (30)

1. Russell, D.W. & Hirata, R.K. Human gene targeting by viral vectors. Nat. Genet. 18, 325-330 (1998).
2. Sands, M.S. & Birkenmeier, E.H. A single-base-pair deletion in the beta-glucuronidase gene accounts for the phenotype of murine mucopolysaccharidosis type VII. Proc. Natl. Acad. Sci. USA 90, 6567-6571 (1993).
3. Miller, D.G., Petek, L.M. & Russell, D.W. Human gene targeting by adeno-associated virus vectors is enhanced by DNA double-strand breaks. Mol. Cell. Biol. 23, 3550-3557 (2003).
4. Soriano, P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21, 70-71 (1999).
5. Liu, X. et al. Targeted correction of single-base-pair mutations with adeno-associated virus vectors under nonselective conditions. J. Virol. 78, 4165-4175 (2004).
6. Koeberl, D.D., Alexander, I.E., Halbert, C.L., Russell, D.W. & Miller, A.D. Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors. Proc. Natl. Acad. Sci. USA 94, 1426-1431 (1997).
7. Trobridge, G., Hirata, R.K. & Russell, D.W. Gene targeting by adeno-associated virus vectors is cell-cycle dependent. Hum. Gene Ther. 16, 522-526 (2005).
8. Gossen, J.A., de Leeuw, W.J., Molijn, A.C. & Vijg, J. Plasmid rescue from transgenic mouse DNA using LacI repressor protein conjugated to magnetic beads. Biotechniques 14, 624-629 (1993).
9. Birkenmeier, E.H. et al. Murine mucopolysaccharidosis type VII. Characterization of a mouse with beta-glucuronidase deficiency. J. Clin. Invest. 83, 1258-1266 (1989).
10. Gillett, P.M. et al. Mucopolysaccharidosis type VII (Sly syndrome) presenting as neonatal cholestasis with hepatosplenomegaly. J. Pediatr. Gastroenterol. Nutr. 33, 216-220 (2001).
11. Wolfe, J.H. et al. High level expression and export of beta-glucuronidase from murine mucopolysaccharidosis VII cells corrected by a double-copy retrovirus vector. Gene Ther. 2, 70-78 (1995).
12. Wolfe, J.H. et al. Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer. Nature 360, 749-753 (1992).
13. Grimm, D. et al. Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy. Blood 102, 2412-2419 (2003).
14. Vijg, J., Dolle, M.E., Martus, H.J. & Boerrigter, M.E. Transgenic mouse models for studying mutations in vivo: applications in aging research. Mech. Ageing Dev. 99, 257-271 (1997).
15. Nickerson, H.D. & Colledge, W.H.A. LacZ-based transgenic mouse for detection of somatic gene repair events in vivo. Gene Ther. 11, 1351-1357 (2004).
16. Vasquez, K.M., Narayanan, L. & Glazer, P.M. Specific mutations induced by triplex-forming oligonucleotides in mice. Science 290, 530-533 (2000).
17. Kren, B.T. et al. Correction of the UDP-glucuronosyltransferase gene defect in the gunn rat model of crigler-najjar syndrome type I with a chimeric oligonucleotide. Proc. Natl. Acad. Sci. USA 96, 10349-10354 (1999).
18. Albuquerque-Silva, J., Vassart, G., Lavinha, J. & Abramowicz, M.J. Chimeraplasty validation. Nat. Biotechnol. 19, 1011 (2001).
19. van der Steege, G. et al. Persistent failures in gene repair. Nat. Biotechnol. 19, 305-306 (2001).
20. Graham, I.R. et al. Gene repair validation. Nat. Biotechnol. 19, 507-508 (2001).
21. Hendrie, P.C. & Russell, D.W. Gene targeting with viral vectors. Mol. Ther. 12, 9-17 (2005).
22. Hirata, R., Chamberlain, J., Dong, R. & Russell, D.W. Targeted transgene insertion into human chromosomes by adeno-associated virus vectors. Nat. Biotechnol. 20, 735-738 (2002).
23. Inoue, N., Hirata, R.K. & Russell, D.W. High-fidelity correction of mutations at multiple chromosomal positions by adeno-associated virus vectors. J. Virol. 73, 7376-7380 (1999).
24. Ware, C.B., Siverts, L.A., Nelson, A.M., Morton, J.F. & Ladiges, W.C. Utility of a C57BL/6 ES line versus 129 ES lines for targeted mutations in mice. Transgenic Res. 12, 743-746 (2003).
25. Sands, M.S. & Barker, J.E. Percutaneous intravenous injection in neonatal mice. Lab. Anim. Sci. 49, 328-330 (1999).
26. Grimm, D., Kern, A., Rittner, K. & Kleinschmidt, J.A. Novel tools for production and purification of recombinant adenoassociated virus vectors. Hum. Gene Ther. 9, 2745-2760 (1998).
27. Gregorevic, P. et al. Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat. Med. 10, 828-834 (2004).
28. Zolotukhin, S. et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther. 6, 973-985 (1999).
29. Gossen, J.A. & Vijg, J. E. coli C: a convenient host strain for rescue of highly methylated DNA. Nucleic Acids Res. 16, 9343 (1988).
30. Sands, M.S. et al. Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates. Lab. Invest. 68, 676-686 (1993).